ArticleJournal of cancer research and clinical oncology2025
Knockdown of FOXD3-AS1 inhibits the progression of prostate cancer by targeting miR-491-5p/PEG10.
Yin Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ArticleJournal of cancer research and clinical oncology2025
Yin Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.